James Flynn - Profile and Investment Details

Investor Profile

James Flynn is a Hedge Fund, Investor, Venture Capital based in New York, United States with a diverse investment portfolio that includes companies such as RubiconMD, Four Points Innovation, AveXis, CathWorks, CorVent Medical, Neos Therapeutics, Syros Pharmaceuticals, Cureatr, Intra-Cellular Therapies, Constellation Pharmaceuticals, Recovery Centers of America, Aprecia Pharmaceuticals, Pairwise Plants LLC, Arvinas, iCAD, Ardelyx, SERMO, TriVascular, OMNIlife science, Headspace, Frontier Medicines, Third Wave Technologies, Generation Bio, Nuvation Bio, Editas Medicine, Pacific Biosciences, CytomX Therapeutics, Audentes Therapeutics, Sollis Therapeutics, SentreHEART, Homology Medicines, Adverum Biotechnologies, Oncorus, Proteon Therapeutics, Rhythm Metabolic, Lumos Pharma, Xeris Pharmaceuticals, Jaguar Gene Therapy, Conventus Orthopaedics, ESSA Pharma, Akari Therapeutics, The Johns Hopkins University, Practice Fusion, Nivalis Therapeutics, Kiniksa Pharmaceuticals, EndoChoice, GrayBug, Tris Pharma, NeoChord, Advantia Health, Ista Pharmaceuticals, Auspex Pharmaceuticals, Wellfount, Synlogic, ARTMS, Fractyl Laboratories, Epion Health, Blade Therapeutics, Acutus Medical, Eligible, Phoenix, REGENXBIO, Infinity Pharmaceuticals, MannKind, TESARO, Dracen Pharmaceuticals, Kolltan Pharmaceuticals, LetsGetChecked, SteadyMed Therapeutics, Element Science, KemPharm, Contessa, MedAvail, Aralez Pharmaceuticals, Hallux, Sema4, IMRIS Inc., Schrödinger, V-Wave, Shockwave Medical, Assertio, Global Blood Therapeutics, Vital Access, Spark Therapeutics. Over time, James Flynn has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether James Flynn is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Black / African American Led, Investment Management, Artificial Intelligence (AI), Information Services, Information Technology (IT), Biotech, Medical Device, Healthcare, Biotechnology, Health and Hospital Services, Predictive Analytics, Food and Beverage, Health IT, Agriculture, Consulting, Health Diagnostics, Digital Health, Medical, Therapeutics, mHealth, Machine Learning, Black / African American Founded, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with James Flynn, as their portfolio suggests a familiarity and interest in this area.

Understanding James Flynn’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.